Literature DB >> 25164738

Misconduct: Japan to learn from biomedical cases.

Tetsuya Tanimoto1, Masahiro Kami1, Kenji Shibuya1.   

Abstract

Mesh：

Year:  2014        PMID： 25164738     DOI： 10.1038/512371d

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Retraction--Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study.

Authors: 
Journal:  Lancet       Date:  2013-09-07       Impact factor: 79.321

2.  Retraction record rocks community.

Authors:  David Cyranoski
Journal:  Nature       Date:  2012-09-20       Impact factor: 49.962

3.  Biomedicine. Faulty drug trials tarnish Japan's clinical research.

Authors:  Dennis Normile
Journal:  Science       Date:  2014-07-04       Impact factor: 47.728

4.  Former Novartis employee arrested over valsartan data.

Authors:  Justin McCurry
Journal:  Lancet       Date:  2014-06-21       Impact factor: 79.321
  4 in total
  4 in total

1.  Human papilloma virus: Restore vaccine trust in Japan.

Authors:  Tetsuya Tanimoto; Eiji Kusumi; Claire Leppold
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

2.  Scientific misconduct: Research integrity guidelines in Japan.

Authors:  Masanori Wada
Journal:  Nature       Date:  2014-10-02       Impact factor: 49.962

Review 3.  A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors:  Tetsuya Tanimoto
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

4.  Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.

Authors:  Akihiko Ozaki; Hiroaki Saito; Yosuke Onoue; Toyoaki Sawano; Yuki Shimada; Yurie Somekawa; Aritsune Tsuji; Tetsuya Tanimoto
Journal:  BMJ Open       Date:  2019-09-06       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.